|
gptkbp:instance_of
|
gptkb:Company
|
|
gptkbp:acquisition
|
Acquired by Virgin Group (2018)
Ancestry.com (attempted)
|
|
gptkbp:analysis
|
Genetic variant interpretation
|
|
gptkbp:brand_recognition
|
High in personal genomics
|
|
gptkbp:business_model
|
Direct-to-consumer
|
|
gptkbp:ceo
|
gptkb:Dr._Anne_Wojcicki
|
|
gptkbp:clinical_trial
|
Genetic health studies
|
|
gptkbp:community_engagement
|
Genetic education
|
|
gptkbp:community_outreach
|
Health awareness programs
|
|
gptkbp:customer_base
|
Over 12 million
|
|
gptkbp:customer_feedback
|
User reviews
|
|
gptkbp:customer_satisfaction
|
High ratings
|
|
gptkbp:customer_support
|
Online assistance
|
|
gptkbp:data_privacy
|
User consent required
|
|
gptkbp:demographics
|
Diverse age groups
|
|
gptkbp:dna_analysis
|
SNP genotyping
|
|
gptkbp:economic_impact
|
International markets
|
|
gptkbp:employees
|
500+
|
|
gptkbp:founded
|
gptkb:2006
|
|
gptkbp:founded_in
|
gptkb:Mountain_View,_California
|
|
gptkbp:founder
|
gptkb:Dr._Anne_Wojcicki
|
|
gptkbp:funding
|
Grants and investments
|
|
gptkbp:future_plans
|
Expand genetic testing services
|
|
gptkbp:headquarters
|
gptkb:Mountain_View,_California
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
23and Me Holding Co.
|
|
gptkbp:industry
|
gptkb:biotechnology
|
|
gptkbp:investment
|
gptkb:Maveron
gptkb:Google
gptkb:Sequoia_Capital
|
|
gptkbp:location
|
gptkb:United_States
|
|
gptkbp:market
|
Personal genomics
|
|
gptkbp:market_launch
|
gptkb:2020_Health_+_Ancestry_Service
|
|
gptkbp:market_position
|
Leader in genetic testing
|
|
gptkbp:marketing_strategy
|
Social media campaigns
|
|
gptkbp:notable_products
|
Carrier Status Report
Health Risk Report
|
|
gptkbp:partnership
|
gptkb:National_Institutes_of_Health
gptkb:Pfizer
gptkb:Glaxo_Smith_Kline
Health organizations
University collaborations
|
|
gptkbp:product
|
Ancestry Service
Health + Ancestry Service
|
|
gptkbp:provides_information_on
|
Research collaborations
|
|
gptkbp:publications
|
Peer-reviewed articles
|
|
gptkbp:regulatory_compliance
|
gptkb:FDA
gptkb:HIPAA
|
|
gptkbp:research_focus
|
Genetic research
|
|
gptkbp:revenue
|
$305 million (2020)
|
|
gptkbp:security
|
Encryption measures
|
|
gptkbp:services
|
DNA testing
|
|
gptkbp:social_responsibility
|
Genetic literacy initiatives
|
|
gptkbp:stock_exchange
|
gptkb:NASDAQ
|
|
gptkbp:stock_symbol
|
ME
|
|
gptkbp:type
|
Genetic testing
|
|
gptkbp:user_engagement
|
Surveys and feedback loops
|
|
gptkbp:user_experience
|
gptkb:Web
|
|
gptkbp:user_interface
|
Mobile app available
|
|
gptkbp:website
|
www.23andme.com
|
|
gptkbp:bfsParent
|
gptkb:23and_Me
|
|
gptkbp:bfsLayer
|
5
|